Cargando…
Advancing precision oncology in metastatic colorectal cancer: The food and drug administration approval of foundation one liquid CDx as a companion diagnostic a correspondence
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521303/ https://www.ncbi.nlm.nih.gov/pubmed/37767464 http://dx.doi.org/10.1177/20363613231204798 |
_version_ | 1785110100423213056 |
---|---|
author | Shahnoor, Syeda Mansha, Manahil Farhat, Solay Maryyum, Adeena Khan, Adil Naseer Khan, Abdul Moiz |
author_facet | Shahnoor, Syeda Mansha, Manahil Farhat, Solay Maryyum, Adeena Khan, Adil Naseer Khan, Abdul Moiz |
author_sort | Shahnoor, Syeda |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10521303 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-105213032023-09-27 Advancing precision oncology in metastatic colorectal cancer: The food and drug administration approval of foundation one liquid CDx as a companion diagnostic a correspondence Shahnoor, Syeda Mansha, Manahil Farhat, Solay Maryyum, Adeena Khan, Adil Naseer Khan, Abdul Moiz Rare Tumors Letter to the Editor SAGE Publications 2023-09-25 /pmc/articles/PMC10521303/ /pubmed/37767464 http://dx.doi.org/10.1177/20363613231204798 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Letter to the Editor Shahnoor, Syeda Mansha, Manahil Farhat, Solay Maryyum, Adeena Khan, Adil Naseer Khan, Abdul Moiz Advancing precision oncology in metastatic colorectal cancer: The food and drug administration approval of foundation one liquid CDx as a companion diagnostic a correspondence |
title | Advancing precision oncology in metastatic colorectal cancer: The food and drug administration approval of foundation one liquid CDx as a companion diagnostic a correspondence |
title_full | Advancing precision oncology in metastatic colorectal cancer: The food and drug administration approval of foundation one liquid CDx as a companion diagnostic a correspondence |
title_fullStr | Advancing precision oncology in metastatic colorectal cancer: The food and drug administration approval of foundation one liquid CDx as a companion diagnostic a correspondence |
title_full_unstemmed | Advancing precision oncology in metastatic colorectal cancer: The food and drug administration approval of foundation one liquid CDx as a companion diagnostic a correspondence |
title_short | Advancing precision oncology in metastatic colorectal cancer: The food and drug administration approval of foundation one liquid CDx as a companion diagnostic a correspondence |
title_sort | advancing precision oncology in metastatic colorectal cancer: the food and drug administration approval of foundation one liquid cdx as a companion diagnostic a correspondence |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521303/ https://www.ncbi.nlm.nih.gov/pubmed/37767464 http://dx.doi.org/10.1177/20363613231204798 |
work_keys_str_mv | AT shahnoorsyeda advancingprecisiononcologyinmetastaticcolorectalcancerthefoodanddrugadministrationapprovaloffoundationoneliquidcdxasacompaniondiagnosticacorrespondence AT manshamanahil advancingprecisiononcologyinmetastaticcolorectalcancerthefoodanddrugadministrationapprovaloffoundationoneliquidcdxasacompaniondiagnosticacorrespondence AT farhatsolay advancingprecisiononcologyinmetastaticcolorectalcancerthefoodanddrugadministrationapprovaloffoundationoneliquidcdxasacompaniondiagnosticacorrespondence AT maryyumadeena advancingprecisiononcologyinmetastaticcolorectalcancerthefoodanddrugadministrationapprovaloffoundationoneliquidcdxasacompaniondiagnosticacorrespondence AT khanadilnaseer advancingprecisiononcologyinmetastaticcolorectalcancerthefoodanddrugadministrationapprovaloffoundationoneliquidcdxasacompaniondiagnosticacorrespondence AT khanabdulmoiz advancingprecisiononcologyinmetastaticcolorectalcancerthefoodanddrugadministrationapprovaloffoundationoneliquidcdxasacompaniondiagnosticacorrespondence |